caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1437175353

Eduardo Partida-RoblesM.D.

CardiologyManati, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$397
Payment records
8
By payment type
Food and Beverage$397
REFERRAL NETWORK

Where Eduardo Partida-Robles's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
DORADO HEALTH INC1237
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
DOCTORS CENTER HOSPITAL INC2560
DORADO HEALTH INC1533
Lorraine Vazquez
Diagnostic Radiology · Manati, PR
1318
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
10,754
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
67
Brand share
15.1%
Top prescribed drugs
Atorvastatin Calcium1,335 claims
Losartan Potassium1,061 claims
Amlodipine Besylate980 claims
Rosuvastatin Calcium648 claims
Irbesartan586 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
143
Unique beneficiaries
—
Total services
192
Distinct HCPCS
6
Medicare payment
$15K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 218 Cardiology providers in PR — above median (cohort median 177).